More about

Yale Cancer Center

News
June 23, 2024
10 min read
Save

‘We cannot pour from an empty cup’: Boundaries, connections can help ensure work-life balance

‘We cannot pour from an empty cup’: Boundaries, connections can help ensure work-life balance

When it comes to work-life balance, clinicians in the past skewed more toward the former.

News
February 11, 2024
3 min read
Save

Study provides ‘increased confidence’ about using taxanes for breast cancer in pregnancy

Study provides ‘increased confidence’ about using taxanes for breast cancer in pregnancy

Taxane-based chemotherapy appeared safe and effective during pregnancy for young women with breast cancer, according to study results.

News
September 05, 2023
4 min read
Save

Immunotherapy may benefit certain patients with penile cancer

Immunotherapy may benefit certain patients with penile cancer

Immune checkpoint inhibitors may confer benefit to certain patients with advanced penile squamous cell carcinoma, according to retrospective study results.

News
July 17, 2023
3 min read
Save

Certain cancer survivors far more likely to die of noncancer-related causes

Certain cancer survivors far more likely to die of noncancer-related causes

Long-term survivors of certain early-stage cancers diagnosed after age 65 years appeared at higher risk for mortality due to noncancer causes, according to study results published in JAMA Network Open.

News
June 27, 2023
4 min read
Save

Combination exhibits ‘impressive’ activity in HPV-negative head and neck cancer

Combination exhibits ‘impressive’ activity in HPV-negative head and neck cancer

The combination of ficlatuzumab and cetuximab extended PFS for patients with pan-refractory recurrent or metastatic head and neck squamous cell carcinoma, according to randomized phase 2 study results.

News
June 07, 2023
2 min read
Save

Erdafitinib improves outcomes vs. chemotherapy in advanced FGFR-altered urothelial cancer

Erdafitinib improves outcomes vs. chemotherapy in advanced <i>FGFR</i>-altered urothelial cancer

CHICAGO — Erdafitinib improved OS, PFS and objective response rate compared with chemotherapy among patients with advanced or metastatic urothelial cancer with select fibroblast growth factor receptor alterations.

News
June 04, 2023
3 min read
Save

Osimertinib after surgery reduces risk for death by 51% in resected EGFR-mutant NSCLC

Osimertinib after surgery reduces risk for death by 51% in resected <i>EGFR</i>-mutant NSCLC

CHICAGO — Adjuvant osimertinib conferred a significant OS benefit vs. placebo among patients with resected, EGFR-mutant, stage IB to IIIA non-small cell lung cancer, according to results of the ADAURA trial presented at ASCO Annual Meeting.

News
April 28, 2023
3 min read
Save

Surveillance mammography common among elderly women for whom it may be unnecessary

Surveillance mammography common among elderly women for whom it may be unnecessary

Many elderly women with a history of breast cancer and shorter life expectancies continue to undergo surveillance mammography, according to data scheduled for presentation at American Society of Breast Surgeons Annual Meeting.

News
April 28, 2023
5 min read
Save

Involving hospitalists in inpatient care improves patient outcomes, oncologist experience

Involving hospitalists in inpatient care improves patient outcomes, oncologist experience

Enlisting hospitalists in the co-management of patients with cancer reduced hospital length of stay, increased hospital capacity for new inpatients and reduced stress among oncologists, according to a study in Journal of Hospital Medicine.

View more